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A metallo-β-lactamase was identified from a clinical sample. The host bacteria was identified to be 
Chryseobacterium indologenes. This preliminary characterization of the enzyme is reported here. 
 





Bacteria escape the action of β-lactam antibiotics by 
producing hydrolytic enzymes,  β-lactamases (Abraham 
and Chain, 1940). These enzymes are able to hydrolyse 
the β-lactam ring  and  give  products which are harmless 
to bacteria. There are four classes of β-lactamases on 
the basis of molecular structure (Ambler, 1975, 1980, 
Ambler and Scott,1978) or functional characteristics 
(Bush,1988, 1989 a, b).  Among them, metallo-β-
lactamases (MBL) which belong to the molecular class B 
constitute a distinct family of β-lactamases (MBL). 
Metallo-β-lactamases from most pathogenic bacteria are 
active with two Zn(II) ions bound to their active site (Ullah 
et al ., 1998;Wang et al, 1998). These enzymes are 
mainly reported in Asia and Europe. During our survey of 
β-lactamase incidence in bacterial resistance to β-lactam 
antibiotics we encountered a strain producing metallo-β-
lactamase. To the best of our knowledge, this is the first 
time that the metallo-β-lactamase has been reported on 
the African continent. The aim of this simple 
communication is to inform the scientific community, 
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MATERIALS AND METHODS 
 
Isolation and identification of the MBL producing strain 
 
The strain which was isolated belongs to non enterobacteriaceae. It  
was collected from a  patient’s urine at  Saint Camille Hospital of 
Ouagadougou and identified by the Api 20 E system ( Bio Merieux 
France).  A solid medium for obtention of pure colonies on plates is 
obtained from Tryptic Soy Agar. 
An overnight preculture is generally performed by inoculating 5 
ml Luria Bertani (LB) liquid medium with  pure colonies of the 
interesting strain. 300 ml of the preculture was then used to 
inoculate 10 ml of liquid medium of LB, and allowed to grow on a 
shaker (250 rpm) at 37°C for 4 h. 
After growing, the cells were harvested by centrifugation at 
8246×g for 15 min. The pellet was redissolved in 500 µl of 
phosphate buffer 100 mM pH 7 and the periplasmic content was 
released by subjecting cells to five cycles of freeze-thaw  (Simpson 
and James, 1982). Then the debris of cells are discarded by 
centrifugation at 14000×g for15 min. The supernatant contains 
crude  β-lactamase activity which was stored for further use. The 
amount of protein of the extract was evaluated using bicinchoninic 
acid (BCA) protein assay kit (Pierce). The specific activity of the 
crude extract was also estimated (Woodford et al, 2000; Rice et al, 
2000). The β-lactamins used as substrate in this study   was 
obtained from  Sigma. 
 Using specific inhibitor such as EDTA (Bush,1988) and substrate  
profiles  allow for the identification of the enzyme molecular class.1 
nM EDTA (the metal trapping agent) completely suppress the 
enzyme’s  activity. Moreover, the preparation is active on most β-
lactams.  
 





                                 
Figure 1. Colonies of clinical Chryseobacterium indologenes strain producing 
metallo-β-lactamase in Ouagadougou Saint Camille Hospital Center. 
          
 
 




Km(µM) Specific activity1 Relative activity2 Efficiency3 of hydrolysis 
benzylpenicillin 33,85 ±1,35 411,5 ±19,17 100 12,15 
ampicillin 40,86 ± 4,10 421,9 ±21,36 103 10,32 
cefalotin 39,47 ±  2,22 315,61 ±18,63 76,69 7,99 
Cefuroxime 18,41 ±  0,23 70,68 ±2,19 17,17 3,83 
cefotaxime 33,55  ± 1,08 66,30 ±6,57 16,11 1,98 
imipenem 12,34  ± 0,96 92,05 ±1,09 22,37 7,46 
 
 
                                                   1µM of substrate hydrolysed per mn and per mg of protein      
                                                   2expressed as percentage of the value of benzylpenicillin 
 




       
    
 
 
Table 2. Kinetic parameters of some  β-lactams for the current preparation  compared to those of IND-1 and IND-2 ( Bellais et al., 1999 
and 2000). 
 
  Preparation IND-1 IND-2 
Substrate 
Km µM Relative Vmax Km µM Relative Vmax Km µM Relative Vmax 
Benzylpenicillin 33,85 100 26,4 100 70 100 
Cefuroxime 18,41 17,17 ∞ 0 ∞ 0 
cefotaxime 33,55 16,11 60 19 10 2,8 
Ceftazidime ∞ 0 765 15 440 0,7 
Imipenem 12,34 22,37 198 90 170 30 
 
 
Hydrolysis of β-lactams are monitored with the crude extracts in 50 
nM phosphate buffer pH 7 at 25OC and recorded on Uvikon 923 
double beam spectrophotometer at fixed wavelength  (235nm for 
benzylpenicillin and ampicillin, 273 nm for cefalotine, 260 nM for 
cefuroxime and cefotaxime, and 300 nM for iminipenem). 
The initial maximal velocity (Vmax)  used to determine  specific 








RESULTS AND DISCUSSION. 
 
The API 20E system (bioMerieux France) successfully 
identified the bacteria as Chyseobacterium (previously 
Flavobacterium) indologenes. The major characteristic of 
this strain is the production of yellow colonies on plates  
(Figure 1) or in liquid culture. When the culture reaches 
the exponential phase, a strong fruity odour is emitted.   
The preparation exhibited a broad substrate spectrum, 
hydrolysing successfully most of the β-lactam antibiotics 
(Table 1) 
The inhibition by EDTA and the ability to hydrolyse 
carbapenem establishes the enzyme as a metallo-β-
lactamase. This enzyme is able to hydrolyse common β-
lactam antibiotics including benzylpenicillin, ampicillin, 
amoxicillin cefalotin and cephaloridin,as well as powerful 
antibiotics such as cefotaxime, cefuroxime and imipenem 
(Table 1). But it is unable to act on ceftazidime another 
third generation β-lactamin and cefalexine , a second 
generation cephalosporin. Its   affinity for imipenem is 
higher than that of the other substrates studied. The 
comparison of kinetic parameters of this enzyme to those 
of two other metallo--lactamase is shown in IND-1 and 
IND-2 (Table2).. It is interesting to note that IND-1 and 
IND-2 are active on ceftazidime,while the enzyme 
preparation does not hydrolyse this antibiotic. 
The existence of metallo-β-lactamase from an extract 
of clinical isolate at the Saint Camille Hospital in 
Ouagadougou is a major revelation in epidemiology of 
bacterial resistance in our country. The background of 
local antibiotherapy can not explain the existence of 
metallo-β-lactamase, because carbapenem are rarely 
used.. Further investigations may be carried out for 
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